Paul Burton - Mar 31, 2024 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Role
Director
Signature
/s/ Elisa Luqman as attorney-in-fact for Paul Burton
Stock symbol
CDIO
Transactions as of
Mar 31, 2024
Transactions value $
$25,000
Form type
4
Date filed
4/8/2024, 03:28 PM
Previous filing
Feb 21, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDIO Common Stock Options Exercise $12.5K +8.8K $1.42 8.8K Mar 31, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDIO Restricted Stock Units Options Exercise $12.5K $37.5K Mar 31, 2024 Common Stock $12.5K $0.00 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the settlement of restricted stock units (RSUs) that vested on March 31, 2024 through the issuance of shares of Common Stock.
F2 Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On March 31, 2024, $12,500 in value of RSUs vested and were settled at the price of $1.42, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.
F3 On January 23, 2024, the reporting person was awarded $50,000 in value of RSUs, $12,500 in value of which vested on March 31, 2024. Subject to continued service with the Issuer on the vesting date, the RSUs will continue to vest $12,500 in value on June 30, 2024, $12,500 in value on September30, 2024 and $12,500 in value on December 31, 2024, based on the closing price of the Issuers common stock on the applicable vesting date.
F4 The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.